Translate to Spanish or other 102 languages!
- Advertisement -
Previous article
More Articles
STHS Edinburg Solidifies Leadership in Advanced Care with Triple Surgical Reaccreditation
There’s no doubt that advancements in surgical technology are changing lives, shifting care away from traditional open procedures toward less invasive, more precise techniques that promote faster healing and improved outcomes.
STHS Heart Earns Level 3 Geriatric Emergency Department Accreditation
Health challenges can affect individuals at any stage of life, but the likelihood of complications rises significantly with age.
Texas Adds New Condition to Mandatory Newborn Screening Tests
The Texas Department of State Health Services added a new enzyme deficiency test on June 1, 2026, to its newborn screening panel, meaning that all Texas newborns are now tested for 60 rare, genetic conditions. Tests for hearing loss and critical congenital heart disease are additional point-of-service tests typically conducted by the birthing center.
Pancreatic Cancer Patients Gain Early Access to Experimental Drug Daraxonrasib Following Fast-Track FDA Decision
The U.S. Food and Drug Administration is announcing that it issued a “safe to proceed” letter to Revolution Medicines, allowing the sponsor to initiate an expanded access treatment protocol (EAP) for its experimental pancreatic cancer drug, daraxonrasib.













